BlackRock Health Sciences Trust (BME)

BME Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	-0.05	-0.03	-0.04	-0.08	-0.08	-0.08
Other Revenue	7.52	7.59	8.23	7.81	6.48	5.32
Revenue	7.47	7.57	8.19	7.73	6.4	5.24
Revenue Growth (YoY)	-6.53%	-7.65%	5.98%	20.76%	22.14%	6.08%
Gross Profit	7.47	7.57	8.19	7.73	6.4	5.24
Selling, General & Admin	6.43	6.64	6.19	6.19	6.35	5.17
Operating Expenses	6.43	6.64	6.19	6.19	6.35	5.17
Operating Income	1.04	0.93	2.01	1.54	0.05	0.07
Interest Expense	-0	-0	-0	-	-	-
Currency Exchange Gain (Loss)	0.02	-0	-0.01	-0.01	-0.01	-0
Other Non Operating Income (Expenses)	7.01	-2.9	0.55	10.12	-9.75	-10.76
EBT Excluding Unusual Items	8.06	-1.98	2.55	11.64	-9.7	-10.69
Gain (Loss) on Sale of Investments	-34.12	25.44	17.47	-38.11	68.83	90.26
Pretax Income	-26.05	23.45	20.02	-26.47	59.13	79.56
Income Tax Expense	-	-	-	-	0.01	-
Net Income	-26.05	23.45	20.02	-26.47	59.12	79.56
Net Income to Common	-26.05	23.45	20.02	-26.47	59.12	79.56
Net Income Growth	-	17.17%	-	-	-25.69%	-0.40%
Shares Outstanding (Basic)	13	13	14	14	13	12
Shares Outstanding (Diluted)	13	13	14	14	13	12
Shares Change (YoY)	-7.31%	-4.94%	0.60%	6.23%	9.13%	10.22%
EPS (Basic)	-2.02	1.77	1.44	-1.91	4.53	6.65
EPS (Diluted)	-2.02	1.77	1.44	-1.91	4.53	6.65
EPS Growth	-	23.26%	-	-	-31.91%	-9.64%
Dividend Per Share	2.900	2.605	2.556	2.556	2.439	2.400
Dividend Growth	13.45%	1.92%	-	4.80%	1.63%	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	13.89%	12.25%	24.48%	19.91%	0.84%	1.31%
Profit Margin	-348.81%	309.96%	244.30%	-342.40%	923.46%	1517.89%
EBIT	1.04	0.93	2.01	1.54	0.05	0.07
EBIT Margin	13.89%	12.25%	24.48%	19.91%	0.84%	1.31%
Effective Tax Rate	-	-	-	-	0.02%	-
Revenue as Reported	7.47	7.57	8.19	7.73	6.4	5.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q